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ABSTRACT
Objective: This study aimed to assess the toxicity of Trapa bispinosa Roxb. starch (TBS) through in vitro and in vivo studies.
Methods: The cytotoxicity of TBS extract (TBSE) was evaluated on RAW 264.7 macrophage and NIH 3T3 fibroblast cell lines and the acute dermal and 
oral toxicities of TBS were analyzed in rats. To access acute dermal toxicity, the rats received a single application of 200, 1000, and 2000 mg/kg BW of 
TBS, while for acute oral toxicity, the rats received a single administration of 300 and 2000 mg/kg BW of TBS. All animals were observed for changes 
in body weight, mortality, and clinical signs of abnormality after application and administration of the TBS.
Results: The in vitro results showed that TBSE at concentrations of 6.25–200 μg/ml was non-cytotoxic to macrophages and fibroblasts. From acute 
toxicity studies, the lethal dose of TBS was considered to be over 2000 mg/kg BW. No mortality, clinical signs of abnormality, or gross pathology were 
detected at necropsy.
Conclusion: TBS is non-toxic in in vitro and in vivo studies. Therefore, TBS can be used as pharmaceuticals excipients or cosmetic ingredients.
Keywords: Trapa bispinosa Roxb., Macrophage, Fibroblast, Acute toxicity, Pharmaceutical excipient, Cosmetic ingredient.
INTRODUCTION
Trapa bispinosa Roxb. (family Trapaceae) or Krajub in Thai is an 
annual edible aquatic angiosperm that is found in lakes, tanks, ponds, 
and shallow water. T. bispinosa Roxb. favors locations with a tropical, 
subtropical, or temperate climate, which include many countries in 
South Europe, Africa, and Asia [1]. The fruit shape is triangular obovoid 
with two horns. The color of a fresh T. bispinosa Roxb. fruit is green but 
turns blackish once it is dehydrated. The pulp color varies from whitish 
to light brown and has a sweet taste. It is a staple ingredient of both 
human and animal diets in some countries, such as India, China, and 
those in Southeast Asia. Regarding its medicinal properties, the whole 
plant is used in Ayurvedic and Unani medicine to treat problems related 
to the stomach, bladder, liver, kidney, spleen, and reproductive organs. 
The common conditions include diarrhea, dysentery, spermatorrhea, 
tuberculosis, dry cough, hemorrhage, strangury, polyuria, sore throat, 
lumbago, fatigue, and dental caries for instance. In recent years, many 
studies reported that T. bispinosa possesses antioxidant, antimicrobial, 
antidiabetic, analgesic, anticancer, and enzymatic activities [2,3].
Starches are widely used as drug excipients and cosmetic ingredients. 
In conventional pharmaceutical applications, they are used as diluents, 
lubricants, absorbents, binders, disintegrants, and thickeners [4]. 
However, the pharmaceutical data of excipients (i.e., acceptable physical 
and chemical stability, safety, and efficacy profile) are required before 
usage and market launch [5]. T. bispinosa Roxb. Starch was previously 
studied as an alternative pharmaceutical excipient by evaluating its 
physicochemical and binder properties. The powder characteristics, 
such as granular shape, particle size, hydration, and swelling capacity, 
are similar to maize and potato starches [6]. Starch materials used in 
pharmaceutical applications are non-toxic and are generally considered 
safe by FDA standards [7]. The toxicological evaluation through safety 
test methods, however, remains necessary as a measure of reducing 
the risks associated with new excipients and natural products, and 
to confirm their safety and effectiveness [8,9]. Since T. bispinosa 
Roxb. is a commonly consumed food, it may be further developed for 
pharmaceutical and cosmetic applications, though little information on 
the toxicity of TBS is available. Therefore, the objective of this study was 
to assess the safety of T. bispinosa Roxb. starch (TBS) through both in 
vitro and in vivo assays.
MATERIALS AND METHODS
Materials
Fresh and matured T. bispinosa Roxb. (BKF200375) fruit were 
purchased from Rai Jum Tid Loe, Suphan Buri, Thailand, in January 
2018. Murine macrophage (RAW 264.7) and murine fibroblast 
(NIH 3T3) cell lines were procured from the American Type Culture 
Collection (ATCC, Manassas, VA). Dulbecco’s Modified Eagle’s Medium 
(DMEM), fetal bovine serum, penicillin, streptomycin, and trypsin-
EDTA were purchased from Gibco, USA. Trypan blue and resazurin were 
purchased from Sigma-Aldrich, USA.
Preparation of test samples
The outer layer of the fruits was peeled off and the fruit pulp (white 
parts) was collected. The collected parts were grounded into powder 
and washed with distilled water until the supernatant became clear. The 
washed TBS was oven-dried at 50°C for 24 h. Dried TBS was then used as 
testing material in acute toxicity studies. TBS was soaked in 70% ethanol 
for 7 days, and the extract was filtered with Whatman filter paper. Excess 
solvent was removed using a rotary evaporator at 50°C. The product is 
designated as TBS extract (TBSE), used for in vitro studies.
Cell culture
Murine macrophage (RAW 264.7) and murine fibroblast (NIH 3T3) 
cell lines were sustained in DMEM containing 10% fetal bovine serum 
and 100 U/ml penicillin and 100 μg/ml streptomycin, and incubated 
at 37°C in a humidified atmosphere of 5% CO2. The macrophages were 
passaged twice a week and dislodged using a cell scraper. Fibroblasts 
were passaged twice a week and dislodged using 0.25% trypsin-EDTA. 
Cell viability was determined with 0.4% trypan blue. Cells with more 
than 85% viability were used in the experiments.
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Determination of cytotoxicity in RAW 264.7 macrophage and NIH 
3T3 fibroblast cells
RAW 264.7 macrophages or NIH 3T3 cells were seeded at a density of 
4×105 cells/ml in a 96-well plate and incubated at 37°C for 24 h. The 
cells were treated with TBSE at various concentrations 6.25, 12.5, 
25, 50, 100, and 200 μg/ml for 24, 48, and 72 h. Cell cytotoxicity was 
determined with resazurin reduction assay, where the treated cells 
were incubated for 2 h at 37°C in 100 μl DMEM containing 50 μg/ml 
resazurin. The reaction mixture absorbance was determined at 560 nm 
against 600 nm. The cell viability of RAW 264.7 macrophages or NIH 






















Female rats (Jcl:SD) were purchased from Nomura Siam International 
Co., Ltd. (Bangkok, Thailand). All animals were healthy, nulliparous, 
and non-pregnant. Eight-week-old rats weighing an average of 
235.50±8.21 g and 217.92±15.69 g were used for acute dermal 
and acute oral toxicity test, respectively. Animals were housed 
in suitable size plastic cages with a filter top cage and kept under 
standard laboratory conditions at room temperature (22±3°C), 
55±10% relative humidity, and a 12 h light-dark cycle. The rats were 
acclimated for 9 days in controlled conditions. The animals were 
provided with food pellets and reverse osmosis water. Changes in 
behavior and any adverse clinical signs were monitored daily. All 
procedures were conducted in agreement with the Institutional 
Animal Care and Use Committee of Naresuan University, Thailand 
(NO. NU-TS620207).
Acute dermal toxicity study
The acute dermal toxicity test of TBS was evaluated in rats according 
to OECD GLP guidelines No. 402 [10]. Twenty-four hours before the 
test, the dorsal hair of rats was shaved using a razor blade. Based on 
procedural guidelines, the test area, which is not less than 10% of the 
body surface area of rats, was cleared. TBS was wetted with sterile 
water and applied at designated doses: 200, 1000, and 2000 mg/kg BW. 
The application site was covered with a porous gauze dressing and 
non-irritating tape. The rats were observed individually for signs of 
behavioral changes after 30 min and 2 and 6 h of application. After 24 h, 
the pad and starch were removed. The test site was wiped with 0.9% 
normal saline. The response of skin irritation and corrosion was then 
observed at 24, 48, and 72 h after the test site was cleansed (Table 1). 
The primary irritation index was calculated as previously reported [11]. 
The clinical signs were monitored and recorded at least once daily for 
14 days. The animals were euthanized by overdosing with thiopental 
on day 15. Gross pathological abnormalities of internal organs – that is, 
heart, liver, kidney, lung, spleen, stomach, and sex organs (uterus and 
ovary), were recorded.
Acute oral toxicity test
The acute oral toxicity test of TBS was evaluated in rats according 
to OECD GLP guidelines No. 423 [12]. TBS was premixed with 
distilled water and administered by gavage feeding at a dose of 
300 mg/kg BW and 2000 mg/kg BW. First, the 300 mg/kg BW dose 
was administered. A dose volume of 2 ml/100 g body weight was 
maintained. The 2000 mg/kg BW dose was further administered 
to another set of animals once no adverse effects were seen after 
the 300 mg/kg BW dose. The clinical signs of toxicity, mortality, 
and behavioral changes were observed and recorded for 30 min, 
1, 2, 3, 4, 24, and 48 h post-administration, and once daily for 14 
days thereafter. Individual animal body weight was recorded on the 
1st, 7th, and 14th days of the study period. At the end of the study, 
all surviving animals were sacrificed by 100 mg/kg BW thiopental 
intraperitoneal injection. External and internal gross pathological 
changes were documented.
Statistical analysis
In vitro results were expressed as mean ± standard error of the mean 
of triplicate experiments. Cell viability was analyzed by one-way 
analysis of variance (ANOVA) followed by Tukey’s (post hoc) using the 
SPSS 22.0 software and p<0.05 was considered statistically significant. 
Descriptive statistics and mean ± standard deviation (SD) were 
presented for in vivo studies.
RESULTS AND DISCUSSION
Cell viability of RAW 264.7 macrophage and NIH 3T3 fibroblast 
cells
In vitro cell cultures benefit in the preliminary evaluation of cytotoxicity 
of many biomaterials [13]. Macrophages are immune cells that play 
important roles in maintaining immune homeostasis. They are a 
component of the innate immunity, bearing roles as the first line 
of defense against pathogens and the initiator of humoral immune 
response that secretes macromolecules to trigger a systemic immune 
response [14,15]. Fibroblasts are connective tissue cells, which have 
a variety of functions including maintenance of the extracellular 
matrix in homeostasis, and reparation of tissue in wound healing and 
regeneration [16].
RAW 264.7 macrophage and NIH 3T3 fibroblast cells were treated with 
variable concentrations of TBSE (6.25, 12.5, 25, 50, 100, and 200 μg/ml) 
for 24, 48, and 72 h. In Fig. 1, the results showed that the viability of 
macrophage cells treated with TBSE at concentrations 6.25–200 μg/
ml for 24, 48, and 72 h was close to the untreated control. Similarly, 
fibroblast cells did not show reduced cell viability when exposed to TBSE 
of the same concentration (Fig. 2). There was no statistical significance 
between the cell viability of the control and TBSE-treated cells. Therefore, 
TBSE at concentrations 6.25–200 μg/ml is non-cytotoxic to macrophages 
and fibroblasts cells after 24, 48, and 72 h of exposure. This corroborates 









Fig. 1: Effects of Trapa bispinosa Roxb. starch extract at variable 
concentrations on macrophage cell viability after 24, 48, and 72 h 
of treatment
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with the results from a previous study that demonstrated the non-
cytotoxic effects of methanolic and ethanolic T. bispinosa Roxb. fruit and 
peels extracts on RAW 264.7 macrophage cells [17].
The properties of TBS as a stabilizer in yogurt [18] and binder in 
diclofenac sodium tablets [6] have been studied. T. bispinosa Roxb. 
was also investigated for its potential development into starch-based 
biomaterials for medical applications such as wound dressing [19] 
and other applications in pharmaceutics and cosmetics [20]. The 
results from this study demonstrate the non-cytotoxic effects of TBS, 
which confirms its safety for further development in medical and 
pharmaceutical applications, or as ingredients of cosmetics products.
Acute dermal toxicity test
There was no evidence of skin irritation and corrosion after 1, 24, 48, and 
72 h contact periods. The primary irritation and corrosion index were 0.0 
(Table 2). TBS at 200, 1000, and 2000 mg/kg BW did not exhibit clinical 
signs of toxicity or mortality after 30 min, 2, 6, and 48 h of exposure or 
at the end of the observation period (14 days). Adverse effects were 
evaluated through changes in body weight and at necropsy. The treatment 
did not have any adverse effect on body weight, which increased 
progressively throughout the study period (Table 3). The external and 
internal gross pathological lesions in rats did not show the difference 
between the control and treated groups. These results indicated the 
safety of the dermal TBS application. Moreover, according to the criteria 
for acute toxicity hazard categories ranked by the United Nations Globally 
Harmonized System of Classification and Labeling of Chemicals (GHS), 
TBS is classified as category 5, which is considered to be relatively low 
acute dermal toxicity in rat [21]. Likewise, the primary dermal irritation 
study of modified gum acacia hydrocolloid, which is used as an emulsifier 
in cosmetics, showed non-irritating to slightly irritating [22].
Acute oral toxicity test
The results for acute oral toxicity of TBS are presented in Table 4. No 
deaths occurred in any animals that received 300 and 2000 mg/kg BW 
of the test item. The treatments did not have an effect on body weight 
during the study period. There were no adverse signs or behavioral 
changes in any treatment group. At necropsy, the test item revealed 
abnormalities in neither external nor internal gross pathological 
observation. Therefore, the oral lethal dose of TBS in rats was greater 
than 2000 mg/kg BW. Based on the GHS criteria for acute toxicity 
hazards, TBS demonstrated low acute oral toxicity [21]. There are 
many toxicity researches on starch that is used as pharmaceutical 
Table 4: Acute oral toxicity tests of Trapa bispinosa Roxb. starch 
in rats
Parameters 300 mg/kg BW 2000 mg/kg BW
Body weight, g (day 0)a 205.98±10.90 229.86±8.33
Body weight, g (day 7)a 232.19±14.58 236.89±9.66
Body weight, g (day 14)a 242.89±13.71 251.91±9.69
Clinical signs (day 1–14)b NAD NAD
Mortality (day 1–14)b NAD NAD
Necropsy (day 15)b NAD NAD
a n=3; Values are expressed as mean±standard deviation. bNAD: No 
abnormalities detected









231.89 240.08 234.94 ± 10.67a
Body weight, 
g (day 7)
246.78 242.18 244.56 ± 7.10a
Body weight, 
g (day 14)










a n=3; Values are expressed as mean ± standard deviation. bNAD: No 
abnormalities detected. cND: No detected
Table 2: The primary irritation/corrosion index of Trapa bispinosa Roxb. starch in rats
Skin characteristics Time (h) Primary irritation/corrosion index Total
200 mg/kg BW 1000 mg/kg BW 2000 mg/kg BW 2000 mg/kg BW 2000 mg/kg BW
Irritation 1 0 0 0 0 0 0
24 0 0 0 0 0 0
48 0 0 0 0 0 0
72 0 0 0 0 0 0
Corrosion 1 0 0 0 0 0 0
24 0 0 0 0 0 0
48 0 0 0 0 0 0
72 0 0 0 0 0 0
Fig. 2: Effects of Trapa bispinosa Roxb. starch extract at variable 
concentrations on fibroblast cell viability after 24, 48, and 72 h of 
treatment
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excipients. Corn starch, a commonly used bulking agent, showed 
no-observed-adverse-effect level after 90 days of oral ingestion at 
10,000 mg/kg BW/d in Sprague Dawley rats [23]. Another example, 
glutamate derived from potato starch is used as a superdisintegrant 
for drug tablets and capsules. Its acute and subacute toxicity study 
results showed no adverse effects on the behavior and gross pathology 
of rats up to the dose of 2000 mg/kg BW [24]. Banana starch, used as a 
viscosity modifier and thickening agent in the pharmaceutical industry, 
incurred neither death nor abnormal behaviors in mice with at the dose 
of 2000 mg/kg BW in an acute oral toxicity study [25].
CONCLUSION
According to the results of this study, TBS showed no cytotoxic effects 
on macrophage and fibroblast cells at concentrations 6.25–200 μg/ml. 
The acute dermal and oral toxicity studies demonstrated that TBS is 
safe and non-toxic up to the dose of 2000 mg/kg BW in rats. Therefore, 
TBS could be used as a pharmaceutical excipient or as an ingredient 
in cosmetic products. However, further subchronic and chronic toxicity 
studies should be conducted to ensure the long-term safety of perpetual 
TBS consumption.
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